# MUTUAL NON-DISCLOSURE AGREEMENT

**This Mutual Non-Disclosure Agreement** (this "Agreement") is entered into as of ____________, 2026 (the "Effective Date"), by and between:

**Meridian Capital Partners, LP**, a Delaware limited partnership with its principal office at 745 Fifth Avenue, 22nd Floor, New York, New York 10151 ("Meridian"), and

**Horizon Therapeutics, Inc.**, a Delaware corporation with its principal place of business at 2200 Gateway Centre Boulevard, Suite 300, Morrisville, North Carolina 27560 ("Horizon").

Meridian and Horizon are each referred to herein as a "Party" and collectively as the "Parties."

## RECITALS

**WHEREAS**, the Parties desire to explore a potential business relationship (the "Purpose"); and

**WHEREAS**, in connection with the Purpose, each Party (in such capacity, the "Disclosing Party") may disclose to the other Party (in such capacity, the "Receiving Party") certain confidential and proprietary information; and

**WHEREAS**, the Parties desire to establish the terms and conditions under which such confidential information will be disclosed, received, and protected;

**NOW, THEREFORE**, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

---

## Section 1. Purpose

The Parties wish to explore a potential business relationship as described in the Recitals above, which may include, without limitation, evaluating potential strategic, investment, licensing, co-development, or other collaborative opportunities between the Parties (collectively, the "Purpose"). Each Party may disclose to the other Party certain Confidential Information as defined herein in connection with the Purpose.

---

## Section 2. Definition of Confidential Information

### 2.1 Confidential Information

"Confidential Information" means any and all non-public, confidential, or proprietary information disclosed by the Disclosing Party to the Receiving Party in connection with the Purpose, whether disclosed orally, in writing, electronically, visually, or by any other means, and whether or not marked or identified as confidential at the time of disclosure, including but not limited to: trade secrets, know-how, inventions, techniques, processes, algorithms, software programs, source code, data, formulas, biological materials, compound libraries, clinical data, regulatory submissions, patent applications, works of authorship, financial information, business plans, product roadmaps, customer and supplier information, marketing strategies, and any analyses, compilations, studies, or other documents prepared by the Receiving Party that contain or otherwise reflect such information.

### 2.2 Exclusions

Confidential Information shall not include information that the Receiving Party can demonstrate by competent evidence:

**(a)** was publicly known and generally available in the public domain prior to the time of disclosure by the Disclosing Party;

**(b)** becomes publicly known and generally available after disclosure through no wrongful act of the Receiving Party;

**(c)** was already in the possession of the Receiving Party at the time of disclosure by the Disclosing Party, as evidenced by the Receiving Party's contemporaneous written records;

**(d)** is independently developed by the Receiving Party without reference to or use of the Disclosing Party's Confidential Information, as evidenced by the Receiving Party's contemporaneous written records; or

**(e)** is rightfully received by the Receiving Party from a third party who is not under an obligation of confidentiality to the Disclosing Party with respect thereto.

---

## Section 3. Obligations of the Receiving Party

### 3.1 Confidentiality

The Receiving Party shall (a) hold the Confidential Information of the Disclosing Party in strict confidence; (b) protect the Confidential Information using the same degree of care it uses to protect its own confidential information of a similar nature, but in no event less than reasonable care; and (c) not use the Confidential Information for any purpose other than the Purpose.

### 3.2 Permitted Disclosures

The Receiving Party may disclose the Disclosing Party's Confidential Information only to its directors, officers, employees, agents, independent contractors, and professional advisors (collectively, "Representatives") who (a) have a need to know such information in connection with the Purpose, and (b) are bound by written obligations of confidentiality at least as restrictive as those contained in this Agreement or, in the case of professional advisors, are bound by professional ethical obligations of confidentiality. The Receiving Party shall be responsible for any breach of the terms of this Agreement by any of its Representatives.

### 3.3 No Reverse Engineering

The Receiving Party shall not reverse engineer, disassemble, or decompile any prototypes, software, samples, biological materials, or other tangible objects that embody the Disclosing Party's Confidential Information.

### 3.4 Residual Knowledge

Notwithstanding any other provision of this Agreement, either Party shall be free to use for any purpose the residuals resulting from access to or work with the Confidential Information of the other Party, provided that such Party shall maintain the confidentiality of the Confidential Information as provided herein. The term "residuals" means information in intangible form that is retained in the unaided memories of persons who have had access to the Confidential Information, including ideas, concepts, know-how, or techniques contained therein. Neither Party shall have any obligation to limit or restrict the assignment of such persons or to pay royalties for any work resulting from the use of residuals. However, this Section 3.4 shall not be deemed to grant to either Party a license under the other Party's copyrights or patents.

---

## Section 4. Compelled Disclosure

In the event that the Receiving Party or any of its Representatives is required by law, regulation, or valid order of a court or governmental agency to disclose any Confidential Information of the Disclosing Party, the Receiving Party shall, to the extent legally permitted, provide the Disclosing Party with prompt written notice of such requirement prior to disclosure so that the Disclosing Party may seek a protective order or other appropriate remedy. Whether or not such protective order or other remedy is obtained, the Receiving Party shall furnish only that portion of the Confidential Information that is legally required to be disclosed and shall exercise commercially reasonable efforts to obtain assurances that confidential treatment will be accorded to such Confidential Information.

---

## Section 5. Return of Materials

### 5.1 Return or Destruction

Upon the written request of the Disclosing Party, or upon termination or expiration of this Agreement, the Receiving Party shall promptly return to the Disclosing Party or destroy all documents, materials, and other tangible manifestations of the Disclosing Party's Confidential Information in the Receiving Party's possession or control, including all copies, summaries, abstracts, and derivative works thereof. Upon request, the Receiving Party shall certify in writing, by an authorized officer, that all such materials have been returned or destroyed.

### 5.2 Archival Copies

Notwithstanding Section 5.1, the Receiving Party may retain copies of the Disclosing Party's Confidential Information (a) to the extent required by applicable law, regulation, or professional standards, and (b) in its automated archival or backup systems, provided that any Confidential Information so retained shall remain subject to the confidentiality obligations of this Agreement for so long as it is retained. The Receiving Party's legal and compliance personnel may retain one copy of the Confidential Information solely for the purpose of monitoring compliance with this Agreement.

---

## Section 6. No Warranty; No Obligation

### 6.1 No Warranty

ALL CONFIDENTIAL INFORMATION IS PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, OR NON-INFRINGEMENT. NEITHER PARTY SHALL BE LIABLE FOR THE ACCURACY OR COMPLETENESS OF ITS CONFIDENTIAL INFORMATION.

### 6.2 No Obligation to Disclose or Proceed

Nothing in this Agreement shall (a) obligate either Party to disclose any particular information to the other Party, (b) obligate either Party to enter into any further agreement or transaction, or (c) create any agency, partnership, joint venture, or other similar relationship between the Parties.

---

## Section 7. Term and Termination

### 7.1 Term

This Agreement shall commence on the Effective Date and shall continue for a period of two (2) years thereafter, unless earlier terminated as provided herein. Either Party may terminate this Agreement at any time upon thirty (30) days' prior written notice to the other Party.

### 7.2 Survival

The obligations of each Party with respect to Confidential Information disclosed during the term of this Agreement shall survive the expiration or termination of this Agreement for a period of three (3) years from the date of such expiration or termination, regardless of the reason for such expiration or termination. Notwithstanding the foregoing, with respect to any Confidential Information that constitutes a trade secret under applicable law, the obligations of confidentiality shall continue for so long as such information remains a trade secret.

---

## Section 8. Remedies

### 8.1 Injunctive Relief

Each Party acknowledges and agrees that any breach or threatened breach of this Agreement by the Receiving Party would cause irreparable harm to the Disclosing Party for which monetary damages would be an inadequate remedy. Accordingly, each Party shall be entitled to seek injunctive or other equitable relief to prevent or restrain any such breach or threatened breach, without the necessity of proving actual damages or posting any bond or other security. Such remedies shall not be deemed to be the exclusive remedies for a breach of this Agreement but shall be in addition to all other remedies available at law or in equity.

### 8.2 Indemnification

Each Party (the "Indemnifying Party") shall indemnify, defend, and hold harmless the other Party and its directors, officers, employees, and agents (collectively, the "Indemnified Parties") from and against any and all claims, damages, losses, liabilities, costs, and expenses (including reasonable attorneys' fees) arising out of or resulting from (a) any breach of this Agreement by the Indemnifying Party or its Representatives, or (b) any unauthorized use or disclosure of the other Party's Confidential Information by the Indemnifying Party or its Representatives. The Indemnifying Party shall also be liable for any indirect, consequential, or special damages suffered by the Indemnified Parties arising from a breach by the Indemnifying Party, provided that the Indemnified Parties shall not be entitled to recover indirect, consequential, or special damages for a breach by the Indemnified Parties of their obligations under this Agreement.

### 8.3 Limitation of Liability

EXCEPT FOR A PARTY'S INDEMNIFICATION OBLIGATIONS UNDER SECTION 8.2, IN NO EVENT SHALL EITHER PARTY'S AGGREGATE LIABILITY UNDER THIS AGREEMENT EXCEED THE GREATER OF (A) ONE MILLION DOLLARS ($1,000,000) OR (B) THE ACTUAL DIRECT DAMAGES SUFFERED BY THE NON-BREACHING PARTY.

---

## Section 9. Non-Solicitation

During the term of this Agreement and for a period of one (1) year following the expiration or termination of this Agreement, neither Party shall, directly or indirectly, solicit, recruit, or hire any employee of the other Party with whom such Party had material contact in connection with the Purpose, without the prior written consent of the other Party. This restriction shall not apply to (a) general solicitations of employment not specifically directed at employees of the other Party, including public job postings, recruitment advertisements, and general use of recruiting agencies, or (b) any employee who has been terminated by the other Party prior to the commencement of employment discussions.

---

## Section 10. General Provisions

### 10.1 Governing Law

This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to its conflict of laws principles.

### 10.2 Forum Selection

Any action, suit, or proceeding arising out of or relating to this Agreement shall be brought exclusively in the state or federal courts located in the State of Delaware. Each Party hereby irrevocably submits to the exclusive jurisdiction of such courts and waives any objection to venue in such courts.

### 10.3 Assignment

Neither Party may assign or transfer this Agreement, in whole or in part, without the prior written consent of the other Party, and any attempted assignment without such consent shall be null and void; provided, however, that either Party may, without the consent of the other Party, assign this Agreement to any entity that directly or indirectly controls, is controlled by, or is under common control with such Party. For purposes of this Section, "control" means the beneficial ownership of twenty percent (20%) or more of the voting securities or equivalent ownership interest of an entity.

### 10.4 Entire Agreement; Supersession

This Agreement constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings, negotiations, and discussions, whether oral or written, between the Parties relating to confidentiality or non-disclosure, including without limitation any prior non-disclosure or confidentiality agreements between the Parties or their respective affiliates.

### 10.5 Amendment and Waiver

This Agreement may not be amended or modified except by a written instrument signed by both Parties. No waiver of any provision of this Agreement shall be effective unless in writing and signed by the waiving Party.

### 10.6 Severability

If any provision of this Agreement is held to be invalid, illegal, or unenforceable, the validity, legality, and enforceability of the remaining provisions shall not in any way be affected or impaired thereby, and such provision shall be reformed to the minimum extent necessary to make it valid, legal, and enforceable while preserving its original intent.

### 10.7 Counterparts

This Agreement may be executed in counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same instrument. Electronic signatures shall be deemed original signatures for all purposes.

### 10.8 Notices

All notices and other communications under this Agreement shall be in writing and shall be deemed given when (a) delivered personally, (b) sent by certified or registered mail, postage prepaid, return receipt requested, (c) sent by a nationally recognized overnight courier, or (d) sent by electronic mail with confirmation of receipt, addressed to the Parties at the addresses set forth above or at such other addresses as may be designated in writing by the respective Parties.

---

**IN WITNESS WHEREOF**, the Parties have executed this Mutual Non-Disclosure Agreement as of the date first written above.

&nbsp;

**MERIDIAN CAPITAL PARTNERS, LP**

By: Meridian Capital Management, LLC, its General Partner

By: ___________________________________

Name: _________________________________

Title: __________________________________

Date: __________________________________

&nbsp;

**HORIZON THERAPEUTICS, INC.**

By: ___________________________________

Name: _________________________________

Title: __________________________________

Date: __________________________________
